Corvus Pharmaceuticals Inc Investor Relations Material
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies for the treatment of cancers. It develops COR 09012, a patient-specific CAR T cell therapy for the potential treatment of hematologic malignancies and solid tumors. The company was incorporated in 2014 and is based in Burlingame, California
Latest company events
Dig deeper into the Corvus Pharmaceuticals Inc fundamentals on Quartr.
- Conference calls from all over the world
- Search for anything across all transcripts
- Consensus estimates
- Comprehensive financial data
- Read the transcripts or scroll the deck
- Slide decks and earnings reports
